0 avis
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Archive ouverte
International audience. While molecular subtypes of glioblastoma (GBM) are defined using gene expression and mutation profiles,we identify a unique subpopulation based on addiction to the high-affinity glucose transporter, Glut3.Although Glut3 is a known driver of a cancer stem cell phenotype, direct targeting is complicated by itsexpression in neurons. Using established GBM lines and patient-derived stem cells, we identify a subsetof tumors within the ‘‘proneural’’ and ‘‘classical’’ subtypes that are addicted to aberrant signaling from integrinavb3, which activates a PAK4-YAP/TAZ signaling axis to enhance Glut3 expression. This defined subpopulationof GBM is highly sensitive to agents that disrupt this pathway, including the integrin antagonistcilengitide, providing a targeted therapeutic strategy for this unique subset of GBM tumors.